Zacks Investment Research has recently initiated coverage of HF Foods Group Inc. HFFG, assigning an "Outperform" recommendation to the company's shares. This bullish stance reflects the company's strategic transformation and robus
Zacks Investment Research has recently initiated coverage of Utah Medical Products, Inc. UTMD with a Neutral recommendation. This report highlights the company's strong positioning in the growing medical device market but also poi
Fintel reports that on May 24, 2024, Morgan Stanley initiated coverage of Azul S.A. - Depositary Receipt () (NYSE:AZUL) with a Equal-Weight recommendation.
Fintel reports that on May 23, 2024, Cantor Fitzgerald initiated coverage of Skye Bioscience (NasdaqGM:SKYE) with a Overweight recommendation.
Fintel reports that on May 23, 2024, Deutsche Bank initiated coverage of Legend Biotech Corporation - Depositary Receipt () (NasdaqGS:LEGN) with a Buy recommendation.
Zacks Investment Research has recently initiated coverage of Twin Disc, Incorporated TWIN with a “Neutral” recommendation. This analysis highlights the company's strategic initiatives, market positioning and financial performance
Zacks Investment Research has recently initiated the coverage of CSP Inc. CSPI, a dynamic IT services and solutions provider based in Lowell, MA, with an “Outperform” recommendation. This bullish stance reflects the company’s stro
Zacks Investment Research has recently initiated the coverage of Preformed Line Products Company PLPC, a stalwart in the construction and maintenance of infrastructure for the energy and telecommunications sectors. With a "Neutral
Zacks Investment Research has recently initiated coverage of Ark Restaurants Corp. ARKR, assigning an "Underperform" recommendation to the company's shares. This bearish stance reflects significant concerns over the company’s rece
Zacks Investment Research has recently initiated the coverage of Where Food Comes From, Inc. WFCF, a prominent third-party verification company in the food industry. Offering a “Neutral” recommendation, Zacks highlights both stren
Zacks Investment Research has recently initiated coverage of Fossil Group, Inc. FOSL, assigning a "Neutral" recommendation. The comprehensive analysis highlights both the potential and challenges faced by the iconic fashion access
Zacks Investment Research has recently initiated coverage of Investors Title Company ITIC with a “Neutral” recommendation. The company's performance and growth potential are compelling, particularly within the expanding title insu
Fintel reports that on May 17, 2024, Oppenheimer initiated coverage of Capricor Therapeutics (NasdaqCM:CAPR) with a Outperform recommendation.
Fintel reports that on May 16, 2024, HC Wainwright & Co. initiated coverage of Dianthus Therapeutics (NasdaqCM:DNTH) with a Buy recommendation.
Zacks Investment Research has recently initiated coverage of Star Group, L.P. SGU, assigning a "Neutral" recommendation. This designation reflects our balanced view of the company's prospects, given its robust dividend growth, sta
Zacks Investment Research has recently initiated coverage of Natural Health Trends Corp. NHTC, assigning a "Neutral" recommendation to the company's shares. This assessment comes amid a mixed outlook for the company, which has dem
Fintel reports that on May 14, 2024, Stephens & Co. initiated coverage of Blueprint Medicines (NasdaqGS:BPMC) with a Overweight recommendation.